Rating History for CNS Pharmasceuticals Inc. (CNSP) by Ladenburg Thalmann
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/28/2020 | Robert Leboyer | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.78 (0.20) |
-88.76% | Details |
 |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 12/28/2020 | Robert Leboyer | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.78 (0.20) |
-88.76% | Details |
|
|||||||
